From research directly or indirectly supported or facilitated by the Foundation

Please click on the links below to see publications over the last three years

2025

Evidence_for_spinal_disinhibition_as_a_pain-genera[1] Pain Reports

Management of Central Poststroke Pain: Systemic Review and Meta-Analysis– The Journal of Pain

2024

Moving pain management programmes into the digital age: development and evaluation of an online PMP for people with chronic pain Frontiers

Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatment- Lancet Neurology

Leveraging deep single-soma RNA sequencing to explore the neural basis of human somatosensation – Nature Neuroscience

Slow touch and ultrafast pain fibres: Revisiting peripheral nerve classification – Clinical Neurophysiology

Small fibre pathology, small fibre symptoms and pain in fibromyalgia syndrome – Nature

Managing chronic pain after breast cancer treatments: are web-based interventions the future? – Current opinion in Supportive & Palliative Care

Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis – Heliyon

Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study .  – Journal of Peripheral Nervous System

Idiopathic Distal Sensory Polyneuropathy and Fibromyalgia Syndrome: A Comparative Phenotyping Study – Pain & Therapy

 

2023

 

Feasibility study of a Behavioural Intervention for Opioid Reduction (BIOR) for patients with chronic non- cancer pain in primary care: a protocol -BMJ

Evidence of genetic background predisposing to CRPS– BMJ

‘A whirlwind of everything’: The lived experience of adolescents with co-occurring chronic pain and mental health symptoms – European Journal of Pain

Co-occurring chronic pain and primary psychological disorders in adolescents: A scoping review– Paediatric & Neonatal Pain

Spinal disinhibition: evidence for a hyperpathia phenotype in painful diabetic neuropathy – Brain Communications

Medicines optimization in acute and chronic pain – Anaesthesia & Intensive Care Medicine

The biology of symptom-based disorders – time to act – Autoimmunity Reviews

The diagnosis of fibromyalgia syndrome – Clinical Medicine

External validation of binary machine learning models for pain intensity perception classification from EEG in healthy individuals – Nature

Artificial intelligence based analysis of corneal confocal microscopy images for diagnosing peripheral neuropathy – Clinical Medicine

Disentangling the relationship between depression and chronic widespread pain: A mendelian randomisation study – Seminars in Arthritis and Rheumatism

2022

Chronic pain is associated with higher risk of developing and being hospitalized for COVID-19: a Mendelian randomization study Rheumatology

Exploring the feasibility and acceptability of a sleep wearable headband among a community sample of chronic pain individuals: An at-home observational study Digital Health Journal 

Aftersensations and lingering pain after examination in patients with fibromyalgia syndrome – Pain Medicine

Feasibility study of a behavioural intervention for opoid reduction for patients with chronic non-cancer pain in primary care – BMJ Open

Discovery of novel targets in complex regional pain syndrome moyse model by transcriptonomics: TNF and JAK-STAT pathways – Pharmacological Research

Intensity-dependant modulation of cortical somatosensory processing during external low-freqeuncy peripheral nerve stimulation in humans – Journal of Neurophysiology

Cardiac autonomic neuropathy in type 1 and 2 diabetes: epidemiology, pathophysiology, and management – Clinical Therapeutics

Complex regional pain syndrome what is the outcome? A systematic review of the course and impact of CRPS at 12 months from symptom onset and beyond – European Journal of Pain

Comparison of amitriptyline supplemented with pregablin, pregablin supplemented with amitriptyline, and duloxetine supplemented with pregablin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): A multicentre, double-blind, randomised crossover trial – The Lancet